Unique ID issued by UMIN | UMIN000046378 |
---|---|
Receipt number | R000052867 |
Scientific Title | Effects of feeding high concentration of lactic acid bacterium producing substance PS-B1on visceral fat |
Date of disclosure of the study information | 2021/12/15 |
Last modified on | 2022/12/13 12:28:29 |
Effects of feeding high concentration of lactic acid bacterium producing substance PS-B1on visceral fat
Effects of feeding high concentration of lactic acid bacterium producing substance on visceral fat
Effects of feeding high concentration of lactic acid bacterium producing substance PS-B1on visceral fat
Effects of feeding high concentration of lactic acid bacterium producing substance on visceral fat
Japan |
Healthy adult
Not applicable |
Others
NO
To investigate the effects of high concentration of lactic acid bacterium producing substance on suppression of visceral fat
Safety,Efficacy
Visceral fat area
Body height, Body weight, Body fat percentage, BMI, Waist length, Blood pressure, Serum cholesterol, HDL-C, LDL-C, Serum triglyceride, Blood glucose , AST, ALT, Gamma-GTP, White blood cell count, Red blood cell count, Hemoglobin, Hematocrit, Platelet count, LDH, ALP, HbA1c, Total protein, Albumin, Creatinine, Uric acid, VAS method (fatigue and defecation feeling)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
Institution is not considered as adjustment factor.
2
Prevention
Food |
The subjects ingested the placebo meal for eight weeks
The subjects ingested the active meal for eight weeks
20 | years-old | <= |
80 | years-old | > |
Male and Female
1) Male and female between 20 and 80 years old
2) Body mass index between 23 and 30
3) Individuals who can refrain from over drinking and over eating during the test period
4) Individuals who understand the purpose and contents of the experiment
1)Individuals taking drugs affect lipid metabolism
2)Those who can not stop taking supplements or health foods that may affect lipid metabolism during the test period
3)Subjects who are contracting or treating severe diabetes and kidney and/or liver diseases
4)Those who have been diagnosed to be dyslipidemia
5)Those who can not stop taking a large amount of lactic acid bacteria beverage during the test period
6)Pregnant women, or women with intending to become pregnant, and lactating woman
7)Individuals participating or intending to participate in other drug administration tests
8)Individuals judged by the doctor to be unsuitable
80
1st name | Kazunari |
Middle name | |
Last name | Tanaka |
Univercity of Nagasaki
Regional Partnership Center
8512195
1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195
0958135216
katanaka@sun.ac.jp
1st name | Hideki |
Middle name | |
Last name | Ito |
Univercity of Nagasaki
Regional Partner Center
8512195
1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195
0958135216
katanaka@sun.ac.jp
Univercity of Nagasaki
Biogenomics Co., Ltd.
Profit organization
Univercity of Nagasaki
1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195
0958135216
katanaka@sun.ac.jp
NO
2021 | Year | 12 | Month | 15 | Day |
Unpublished
80
Completed
2021 | Year | 10 | Month | 26 | Day |
2022 | Year | 03 | Month | 28 | Day |
2022 | Year | 05 | Month | 28 | Day |
2022 | Year | 10 | Month | 30 | Day |
2021 | Year | 12 | Month | 15 | Day |
2022 | Year | 12 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052867